Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

76.89EUR
11:35am EDT
Price Change (% chg)

€0.07 (+0.09%)
Prev Close
€76.82
Open
€77.00
Day's High
€77.74
Day's Low
€76.51
Volume
2,381,740
Avg. Vol
2,209,927
52-wk High
€80.74
52-wk Low
€68.29

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer... (more)

Overall

Beta: 0.55
Market Cap (Mil.): €101,604.40
Shares Outstanding (Mil.): 1,322.62
Dividend: 2.80
Yield (%): 3.64

Financials

  SASY.PA Industry Sector
P/E (TTM): 27.13 35.68 36.12
EPS (TTM): 2.83 -- --
ROI: -- 18.88 18.15
ROE: -- 19.60 18.97
Search Stocks

UPDATE 1-Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints

(Adds CEO comments, details on reduced heart risk, drug background)

12:45pm EDT

Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials

PARIS - A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

8:06am EDT

Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials

PARIS, July 30 - A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

8:00am EDT

Hungarian competition watchdog probes Sanofi subsidiary

BUDAPEST/PARIS - Hungary's competition watchdog GVH has raided the Hungarian headquarters of French drug maker Sanofi as the first step of proceedings against the firm for suspected abuse of its dominant market position.

29 Jul 2014

UPDATE 1-Hungarian competition watchdog probes Sanofi subsidiary

BUDAPEST/PARIS, July 29 - Hungary's competition watchdog GVH has raided the Hungarian headquarters of French drug maker Sanofi as the first step of proceedings against the firm for suspected abuse of its dominant market position.

29 Jul 2014

Hungary launches probe against Sanofi-Aventis

BUDAPEST, July 29 - Hungary's competition watchdog GVH has raided the Hungarian headquarters of French drug maker Sanofi-Aventis as the first step of a proceedings against the firm for a suspected abuse of its dominant market position, GVH said on Tuesday.

29 Jul 2014

IATA seeks meeting with Venezuela president over money owed to airlines

BERLIN, July 28 - A leading air transport industry body has called for a top-level meeting with the Venezuelan president to discuss ways to restore over $4 billion of airlines' money that is trapped in the country due to its currency controls.

28 Jul 2014

Sanofi held talks with Abbott, Mylan about mature drugs: document

PARIS - Sanofi has held talks with Abbott Laboratories , Mylan and private equity firms over the possible sale of a 6.3 billion euro ($8.5 billion) portfolio of mature drugs, according to an internal document seen by Reuters.

16 Jul 2014

UPDATE 1-Sanofi held talks with Abbott, Mylan about mature drugs -document

* Portfolio has sales of 2.1 bln eur, enterprise value 6.3 bln eur

16 Jul 2014

Sanofi held talks with Abbott, Mylan on mature drugs -document

PARIS, July 16 - Sanofi has held talks with Abbott Laboratories, Mylan and private equity firms over the possible sale of a 6.3 billion euro ($8.5 billion) portfolio of mature drugs, according to an internal document seen by Reuters.

16 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks